Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 October 2020 | Story Ruan Bruwer | Photo BackpagePix
Khanyisa Chawane, a Protea player, should be one of the stars for the Free State Crinums in the Telkom Netball League. She was the Player of the League in 2018.

Having to play 11 matches in so many days before the knockout stage will be a daunting task, but their fitness levels are up to standard, says the coach of the Free State netball team. Burta de Kock of KovsieSport will again guide the Free State Crinums in the Telkom Netball League, which will be taking place between 14 and 27 October in Bloemfontein.

All but one of the 12 members of the team are studying at the University of the Free State (UFS).

“Planning will be of the utmost importance to manage the load on the players. We also have four players (Rolene Streutker, Chanel Vrey, Boitumelo Mahloko, and Refiloe Nketsa) who will participate in the South African U21 team that will play five invitational matches during the competition,” said De Kock.

In previous years, the competition took place over four to six weeks, but now it had to be fitted into two weeks due to COVID-19.

“So, it will be a tall order to play so many matches, but an exciting challenge. I believe the hard work the players had put in during the lockdown period will bear fruit. They were exceptional and very determined to stay in shape.”

The Crinums won the first three years of the competition, but couldn’t reach the final in the following three years. Apart from the 11 Kovsies in the Crinums team, there are 9 current or former UFS students in other teams participating in the league. 

They are Zandré Smit, Bianca Pienaar, Dané Klopper, Arné Fourie, Bethenie du Raan (all Northern Cape Diamonds), Maryke Coetzee, Danelle van der Heever (both Mpumalanga Sunbirds), Rieze Straeuli (Western Cape Tornados), and Alicia Puren (KZN Kingdom Stars).

The Crinums team: Boitumelo Mahloko, Ané Retief, Jana Scholtz, Khanyisa Chawane, Lefébre Rademan (captain), Sikholiwe Mdletshe, Claudia van den Berg, Bianca de Wee, Rolene Streutker, Chanel Vrey, Lerato Chabwe, and Refiloe Nketsa.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept